SCHEMBL13699010

SCHEMBL13699010

Fc1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
TAAR1 Q96RJ0 3/20 0.44
ESR2 Q92731 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2A6 P11509 1/20 0.42
MAOA P21397 1/20 0.40
KIF11 P52732 1/20 0.40
EGFR P00533 1/20 0.40
KMO O15229 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP3A4 P08684 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21578555 0.97 ALDH1A1 (0.50) ALDH1A1TAAR1ESR2SLC6A2SLC6A4
SCHEMBL18818912 0.95 TAAR1 (0.52) ALDH1A1TAAR1ESR2MAOAKMO
SCHEMBL411336 0.94 ALDH1A1 (0.53) ALDH1A1TAAR1ESR2SLC6A2SLC6A4
Biphenyl SCHEMBL28360045 0.94 ALDH1A1 (0.53) ALDH1A1TAAR1ESR2SLC6A2SLC6A4
SCHEMBL16887401 0.92 ALDH1A1 (0.50) ALDH1A1TAAR1ESR2SLC6A2SLC6A4
SCHEMBL28102063 0.87 TAAR1 (0.61) ALDH1A1TAAR1ESR2MAOAKMO
SCHEMBL13682555 0.86 ALDH1A1 (0.50) ALDH1A1TAAR1CYP1A2KIF11MAPK1
SCHEMBL26771690 0.86 ALDH1A1 (0.50) ALDH1A1TAAR1CYP1A2KIF11MAPK1
SCHEMBL18519108 0.84 L3MBTL1 (0.48) ALDH1A1MAPK1
SCHEMBL4332773 0.84 ALDH1A1 (0.75) ALDH1A1TAAR1SLC6A4CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 US disclosed
US-11858952-B2 Compound and color conversion film comprising same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-11818932-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-14 US disclosed
CN-117044428-A Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element 东曹株式会社 2023-11-10 CN disclosed
US-11706973-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-18 US disclosed
US-11696496-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-04 US disclosed
US-11678566-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-06-13 US disclosed
EP-3246963-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-05-31 EP disclosed
US-20230132356-A2 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-04-27 US disclosed
US-11569452-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-31 US disclosed
CN-107344940-A BTK inhibitor and application thereof 广东东阳光药业有限公司 2017-11-14 CN disclosed
US-20170155048-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-9564601-B2 Condensed-cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-07 US disclosed
EP-3101088-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2016-12-07 EP disclosed
EP-2814906-B1 SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-10-19 EP disclosed
EP-2448035-B1 Organic light-emitting device SAMSUNG DISPLAY CO LTD (KR) 2014-06-11 EP disclosed
WO-2013120577-A1 SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2013-08-22 WO disclosed
EP-2096108-A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same Gracel Display Inc. (KR) 2009-09-02 EP disclosed
US-20090200926-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-08-13 US disclosed
EP-2067767-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706973-B2 Condensed cyclic compound and organic light-emitting device including the same C1S, CCNT1, C9 ALDH1A1 246/4885TAAR1 1047/4885ESR2 228/4885
US-20230132356-A2 ORGANIC LIGHT-EMITTING DEVICE L1CAM, CRY1, LAGE3 ALDH1A1 108/4885TAAR1 2590/4885ESR2 168/4885
US-11678566-B2 Organometallic compound and organic light-emitting device including the same L1CAM, AP1M1, PYM1 ALDH1A1 368/4885TAAR1 1826/4885ESR2 831/4885
US-20090200926-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same NQO1, NDUFS2, NDUFS5 ALDH1A1 96/4885TAAR1 3090/4885ESR2 472/4885
US-11569452-B2 Organic light-emitting device CRY1, TRPA1, CRY2 ALDH1A1 268/4885TAAR1 2062/4885ESR2 826/4885
US-11858952-B2 Compound and color conversion film comprising same BLVRB, CDYL, CRY1 ALDH1A1 689/4885TAAR1 3952/4885ESR2 1967/4885
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT AXIN2, FZD7, SLC39A3 ALDH1A1 3265/4885TAAR1 1542/4885ESR2 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.